ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid

C109H106N32O15 — CID 165035526

IUPACethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid
SMILESC=C(O)Cn1cnc2nc(N3CCN(c4ccc(O)cc4)CC3)nc(-n3nc(C(=O)CC)c4ccccc43)c21.C=C(O)Cn1cnc2nc(N3CCN(c4ccc(O)cc4)CC3)nc(-n3nc(C(=O)OCC)c4ccccc43)c21.C=C(O)c1cccc2c1cnn2-c1nc(N2CCN(c3ccc(O)cc3)CC2)nc2c1ncn2CC(=O)O.CCC(=O)c1nn(-c2nc(N3CCN(c4ccc(O)cc4)CC3)nc3c2ncn3CC(=O)O)c2ccccc12
InChIInChI=1S/C28H28N8O4.C28H28N8O3.C27H26N8O4.C26H24N8O4/c1-3-40-27(39)23-21-6-4-5-7-22(21)36(32-23)26-24-25(29-17-35(24)16-18(2)37)30-28(31-26)34-14-12-33(13-15-34)19-8-10-20(38)11-9-19;1-3-23(39)24-21-6-4-5-7-22(21)36(32-24)27-25-26(29-17-35(25)16-18(2)37)30-28(31-27)34-14-12-33(13-15-34)19-8-10-20(38)11-9-19;1-2-21(37)23-19-5-3-4-6-20(19)35(31-23)26-24-25(34(16-28-24)15-22(38)39)29-27(30-26)33-13-11-32(12-14-33)17-7-9-18(36)10-8-17;1-16(35)19-3-2-4-21-20(19)13-28-34(21)25-23-24(33(15-27-23)14-22(37)38)29-26(30-25)32-11-9-31(10-12-32)17-5-7-18(36)8-6-17/h4-11,17,37-38H,2-3,12-16H2,1H3;4-11,17,37-38H,2-3,12-16H2,1H3;3-10,16,36H,2,11-15H2,1H3,(H,38,39);2-8,13,15,35-36H,1,9-12,14H2,(H,37,38)
InChIKeyNIAFHJBGXYOZOY-UHFFFAOYSA-N
MW2104.26 g/mol
LogP12.99
Rot. Bonds27

About ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid

ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid (PubChem CID 165035526) has the molecular formula C109H106N32O15 and a molecular weight of 2104.26 g/mol. Its IUPAC name is ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid.

Molecular Properties

Compound Nameethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid
PubChem CID165035526
Molecular FormulaC109H106N32O15
Molecular Weight2104.26 g/mol
Exact Mass2102.85
IUPAC Nameethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid
SMILESC=C(O)Cn1cnc2nc(N3CCN(c4ccc(O)cc4)CC3)nc(-n3nc(C(=O)CC)c4ccccc43)c21.C=C(O)Cn1cnc2nc(N3CCN(c4ccc(O)cc4)CC3)nc(-n3nc(C(=O)OCC)c4ccccc43)c21.C=C(O)c1cccc2c1cnn2-c1nc(N2CCN(c3ccc(O)cc3)CC2)nc2c1ncn2CC(=O)O.CCC(=O)c1nn(-c2nc(N3CCN(c4ccc(O)cc4)CC3)nc3c2ncn3CC(=O)O)c2ccccc12
InChIInChI=1S/C28H28N8O4.C28H28N8O3.C27H26N8O4.C26H24N8O4/c1-3-40-27(39)23-21-6-4-5-7-22(21)36(32-23)26-24-25(29-17-35(24)16-18(2)37)30-28(31-26)34-14-12-33(13-15-34)19-8-10-20(38)11-9-19;1-3-23(39)24-21-6-4-5-7-22(21)36(32-24)27-25-26(29-17-35(25)16-18(2)37)30-28(31-27)34-14-12-33(13-15-34)19-8-10-20(38)11-9-19;1-2-21(37)23-19-5-3-4-6-20(19)35(31-23)26-24-25(34(16-28-24)15-22(38)39)29-27(30-26)33-13-11-32(12-14-33)17-7-9-18(36)10-8-17;1-16(35)19-3-2-4-21-20(19)13-28-34(21)25-23-24(33(15-27-23)14-22(37)38)29-26(30-25)32-11-9-31(10-12-32)17-5-7-18(36)8-6-17/h4-11,17,37-38H,2-3,12-16H2,1H3;4-11,17,37-38H,2-3,12-16H2,1H3;3-10,16,36H,2,11-15H2,1H3,(H,38,39);2-8,13,15,35-36H,1,9-12,14H2,(H,37,38)
InChIKeyNIAFHJBGXYOZOY-UHFFFAOYSA-N
XLogP12.99
TPSA548.25 Ų
H-Bond Donors9
H-Bond Acceptors45
Rotatable Bonds27
Heavy Atoms156
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002104.26
LogP ≤ 512.99
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1045

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}

Analyze ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid?
The IUPAC name of ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid (CID 165035526) is ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid.
What is the SMILES notation for ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid?
The canonical SMILES for ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid is C=C(O)Cn1cnc2nc(N3CCN(c4ccc(O)cc4)CC3)nc(-n3nc(C(=O)CC)c4ccccc43)c21.C=C(O)Cn1cnc2nc(N3CCN(c4ccc(O)cc4)CC3)nc(-n3nc(C(=O)OCC)c4ccccc43)c21.C=C(O)c1cccc2c1cnn2-c1nc(N2CCN(c3ccc(O)cc3)CC2)nc2c1ncn2CC(=O)O.CCC(=O)c1nn(-c2nc(N3CCN(c4ccc(O)cc4)CC3)nc3c2ncn3CC(=O)O)c2ccccc12.
What is the InChIKey of ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid?
The InChIKey is NIAFHJBGXYOZOY-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H28N8O4.C28H28N8O3.C27H26N8O4.C26H24N8O4/c1-3-40-27(39)23-21-6-4-5-7-22(21)36(32-23)26-24-25(29-17-35(24)16-18(2)37)30-28(31-26)34-14-12-33(13-15-34)19-8-10-20(38)11-9-19;1-3-23(39)24-21-6-4-5-7-22(21)36(32-24)27-25-26(29-17-35(25)16-18(2)37)30-28(31-27)34-14-12-33(13-15-34)19-8-10-20(38)11-9-19;1-2-21(37)23-19-5-3-4-6-20(19)35(31-23)26-24-25(34(16-28-24)15-22(38)39)29-27(30-26)33-13-11-32(12-14-33)17-7-9-18(36)10-8-17;1-16(35)19-3-2-4-21-20(19)13-28-34(21)25-23-24(33(15-27-23)14-22(37)38)29-26(30-25)32-11-9-31(10-12-32)17-5-7-18(36)8-6-17/h4-11,17,37-38H,2-3,12-16H2,1H3;4-11,17,37-38H,2-3,12-16H2,1H3;3-10,16,36H,2,11-15H2,1H3,(H,38,39);2-8,13,15,35-36H,1,9-12,14H2,(H,37,38).
What are the key properties of ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid?
ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid has a molecular weight of 2104.26 g/mol, XLogP of 12.99, 27 rotatable bonds, 9 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl 1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazole-3-carboxylate;2-[6-[4-(1-hydroxyethenyl)indazol-1-yl]-2-[4-(4-hydroxyphenyl)piperazin-1-yl]purin-9-yl]acetic acid;1-[1-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-7-(2-hydroxyprop-2-enyl)purin-6-yl]indazol-3-yl]propan-1-one;2-[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-6-(3-propanoylindazol-1-yl)purin-9-yl]acetic acid is sourced from PubChem (CID 165035526), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).